e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Pathogenesis of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep apnea in patients with implantable cardioverter defibrillator
L. Lüthje, T. Raupach, D. Dajani, J. Szych, S. Andreas (Göttingen, Germany)
Source:
Annual Congress 2005 - Pathogenesis of OSA
Session:
Pathogenesis of OSA
Session type:
Thematic Poster Session
Number:
2332
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Lüthje, T. Raupach, D. Dajani, J. Szych, S. Andreas (Göttingen, Germany). Sleep apnea in patients with implantable cardioverter defibrillator. Eur Respir J 2005; 26: Suppl. 49, 2332
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Validation of apneas and hypopneas detection by an implantable cardioverter defibrillator impedance-based respiration sensor: AIRLESS study
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017
Severe bradyarrhythmias in pts with sleep apnea hypopnea syndrome (OSAHS) and the effect of CPAP treatment. A long-term study with the use of implantable loop recorders
Source: Eur Respir J 2003; 22: Suppl. 45, 23s
Year: 2003
Implantable cardiac devices in sleep apnea diagnosis: a systematic review and meta-analysis
Source: Sleep and Breathing Conference 2021
Year: 2021
Day-night pattern of defibrillator shocks in patients with chronic heart failure: The impact of Cheyne-Stokes respiration and obstructive sleep apnoea
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Implantable cardiac devices in sleep apnoea diagnosis: a systematic review and meta-analysis
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021
Nocturnal overdrive pacing in pacemaker patients with obstructive sleep apnea
Source: Annual Congress 2004 - Non-CPAP therapy for OSA
Year: 2004
Prediction of sleep apnea severity using a textile-based electrocardiogram monitoring device
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Utility of a portable recording device in the assessment of sleep apnoea/hypopnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 193s
Year: 2006
Overdrive atrial pacing does not improve obstructive sleep apnoea syndrome
Source: Eur Respir J 2005; 25: 343-347
Year: 2005
Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome
Source: Eur Respir J 2003; 21: 253-259
Year: 2003
CPAP and atrial overdrive pacing in the treatment of obstructive sleep apnea syndrome
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004
Validation of the STOP-BANG questionnaire as a screening tool for sleep apnoea in patients undergoing ablation for paroxysmal atrial fibrillation
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
No benefit of overdrive atrial pacing for treatment of obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 23s
Year: 2003
Respiratory function in sleep apnea syndrome with atrial pacing
Source: Eur Respir J 2002; 20: Suppl. 38, 408s
Year: 2002
Evaluation of a cardiorespiratory polygraphic device in patients with suspected sleep apnoea/hypopnoea syndrome (SAHS)
Source: Eur Respir J 2004; 24: Suppl. 48, 117s
Year: 2004
Influence of smoking dosage and chronic obstructive lung disease on the incidence of appropriate therapies and mortality in patients with structural heart disease and an implantable cardioverter defibrillator
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014
A portable accelerometer-based device for apnea diagnosis
Source: Annual Congress 2008 - Diagnostic aspects of sleep apnoea
Year: 2008
Diagnostic efficacy of the KaLinix® intelligent medical device for diagnosis of obstructive sleep apnea and hypopnea syndrome.
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020
Sleep-related breathing disorders in patients under cardiac resynchronization therapy with ventricular pacing
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Atrial overdrive pacing and sleep apnea syndrome
Source: Annual Congress 2004 - Non-CPAP therapy for OSA
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept